NeuroPace Maintains FY24 Revenue Guidance Of $73M-$77M, Est $75.205M
Portfolio Pulse from Benzinga Newsdesk
NeuroPace has reaffirmed its FY24 revenue guidance of $73M-$77M, in line with estimates of $75.205M. The company expects a gross margin between 72% and 74%, and total operating expenses of $80M-$84M, which includes around $12M in stock-based compensation. Additionally, NeuroPace extended the maturity date of its term loan to September 30, 2026.

May 08, 2024 | 9:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NeuroPace maintains its FY24 revenue guidance, expects gross margins of 72%-74%, and operating expenses of $80M-$84M, including $12M in stock-based compensation. The term loan's maturity is extended to 2026.
Maintaining revenue guidance suggests confidence in the company's financial outlook, which could positively influence investor sentiment. The extension of the loan maturity date may also be viewed positively as it indicates financial flexibility and potentially less near-term financial pressure. However, the high operating expenses, including significant stock-based compensation, could be a concern for profitability.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100